features: Multiple Myeloma
Homozygous BCMA deletion in response to ide-cel in myeloma patient
Immunological approaches to the treatment of multiple myeloma have rapidly evolved in recent years. One of the most promising fields…
Post-ASH 2020 Virtual iwAL Workshop Presentations
Presentations from the virtual post-ASH 2020 Virtual iwAL Workshop
The Transplant Sessions: post-ASH 2020 roundtable discussion
A session with experts Bruce Levine and Christian Chabannon, who discuss the exciting updates in transplantation and cell therapy from…
The Myeloma Sessions: UK post-ASH 2020 discussion
A session with UK experts Rakesh Popat and Karthik Ramasamy, who discuss the latest myeloma news from ASH 2020.
The Myeloma Sessions: post-ASH 2020 roundtable discussion
A session with experts María-Victoria Mateos, Nina Shah & Thomas Martin, who discuss the latest myeloma updates from ASH 2020.
The VJ Sessions:
Roundtable discussions with leading experts in hemonc
VJHemOnc brings you roundtable discussions with leading hematological experts in myeloma, AML, CLL, ALL, lymphoma, MDS and MPNs.
SOHO Italy 2020 Virtual Meeting
VJHemOnc is proud to present the SOHO Italy 2020 Virtual Meeting, which took place on the 22nd-24th of September 2020.
NYC-Miami Myeloma MRD 2020 Virtual Meeting
VJHemOnc is proud to present the NYC-Miami Myeloma MRD 2020 Virtual Meeting, which took place on the 8th of October…
Real-world effectiveness of IRd in R/R myeloma
Article on the TOURMALINE-MM1 study of ixazomib, lenalidomide and dexamethasone
Advances in Myeloma Precursor Conditions
Presentations from the virtual meeting held by MMRF & DFCI with VJHemOnc as media partner
FDA gives the go-ahead for belantamab mafodotin in relapsed/refractory multiple myeloma
The U.S. Food and Drug Administration (FDA) has approved belantamab mafodotin-blmf (Blenrep®) for the treatment of patients with relapsed/refractory multiple…
The Myeloma Sessions: Evolving management of myeloma & COVID-19
A four-part session with experts Paul Richardson, María-Victoria Mateos, Evangelos Terpos and Ajai Chari who discuss evolving strategies for the…
EHA 2020 Top Picks
VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!
Treatment of multiple myeloma continues to evolve
Exclusive podcast with Prof. Graham Jackson who explains the current treatment landscape in multiple myeloma.
iwCAR-T 2019 e-learning
VJHemOnc is pleased to bring you e-learning webcasts from iwCAR-T 2019– explore updates in CAR T-cell therapy!